Brown Advisory’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $211K | Sell |
7,639
-6,441
| -46% | -$178K | ﹤0.01% | 1282 |
|
2025
Q1 | $399K | Buy |
14,080
+6,755
| +92% | +$192K | ﹤0.01% | 1052 |
|
2024
Q4 | $305K | Sell |
7,325
-772
| -10% | -$32.1K | ﹤0.01% | 1150 |
|
2024
Q3 | $541K | Sell |
8,097
-477
| -6% | -$31.9K | ﹤0.01% | 980 |
|
2024
Q2 | $1.02M | Buy |
8,574
+1,124
| +15% | +$133K | ﹤0.01% | 769 |
|
2024
Q1 | $794K | Buy |
7,450
+1,687
| +29% | +$180K | ﹤0.01% | 833 |
|
2023
Q4 | $573K | Sell |
5,763
-379
| -6% | -$37.7K | ﹤0.01% | 901 |
|
2023
Q3 | $634K | Buy |
6,142
+2,880
| +88% | +$297K | ﹤0.01% | 852 |
|
2023
Q2 | $396K | Buy |
3,262
+58
| +2% | +$7.05K | ﹤0.01% | 956 |
|
2023
Q1 | $492K | Buy |
3,204
+207
| +7% | +$31.8K | ﹤0.01% | 911 |
|
2022
Q4 | $538K | Sell |
2,997
-186
| -6% | -$33.4K | ﹤0.01% | 893 |
|
2022
Q3 | $376K | Buy |
3,183
+481
| +18% | +$56.8K | ﹤0.01% | 923 |
|
2022
Q2 | $386K | Buy |
2,702
+49
| +2% | +$7K | ﹤0.01% | 903 |
|
2022
Q1 | $457K | Buy |
2,653
+317
| +14% | +$54.6K | ﹤0.01% | 879 |
|
2021
Q4 | $593K | Sell |
2,336
-10
| -0.4% | -$2.54K | ﹤0.01% | 834 |
|
2021
Q3 | $903K | Sell |
2,346
-63
| -3% | -$24.2K | ﹤0.01% | 712 |
|
2021
Q2 | $566K | Buy |
2,409
+246
| +11% | +$57.8K | ﹤0.01% | 816 |
|
2021
Q1 | $283K | Buy |
+2,163
| New | +$283K | ﹤0.01% | 958 |
|